InvestSMART

nanollose Limited (ASX:NC6)

ALERT: Price-sensitive ASX Announcement for NC6
Current share price for NC6 : $0.076 0 (0%)+
Release
29 Aug 2025 2:04PM
Price at Release
$0.076
Full Release
download
Summary
Nanollose Limited's annual report for the financial year ending June 30, 2025, highlights a financial performance marked by significant losses. The company issued new shares and options, structured as part of remuneration incentives and consultancy agreements. Despite a comprehensive loss for the year, Nanollose Limited raised capital through share issues and restructured options extensively, indicating efforts to stabilize and enhance financial viability. Key management personnel received equity-based compensation as part of strategic measures to align management incentives with company performance. The report, audited by RSM Australia Partners, also details corporate governance and financial strategies, reflecting the company’s ongoing adjustments to its operational model.
Key Points
  • Total comprehensive loss for the year of $1,426,452.
  • Share issues and share-based payments were utilized for raising funds and compensating directors.
  • The company's focus on R&D was supported by incentive receipts.
  • Nanollose Limited managed cash flow through strategic share issuances and cost management.
  • Significant options activity, with several types of options issued and expired.
  • The audit was conducted by RSM Australia Partners.
  • The company is adjusting its financial strategies and management incentives.
  • Equity-based remuneration packages were implemented to align key personnel with company goals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.